Lipoprotein Insulin Resistance Score and Mortality Risk Stratification in Heart Failure

Sarah Turecamo1, Carolina G Downie1, Anna Wolska2

  • 1Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.

Insights

In heart failure patients, a higher lipoprotein insulin resistance (LP-IR) score is linked to reduced mortality. This inverse relationship may be influenced by smaller high-density lipoprotein (HDL) particle size.

Area of Science:

  • Cardiology
  • Metabolic Syndrome
  • Lipidomics

Background:

  • Total serum cholesterol is paradoxically linked to lower mortality in heart failure patients.
  • Investigating lipoprotein subfractions may clarify this inverse cholesterol-mortality association.

Purpose of the Study:

  • To examine the relationship between the lipoprotein insulin resistance (LP-IR) score, derived from lipoprotein subfractions, and all-cause mortality in a heart failure cohort.
  • To identify specific lipoprotein parameters contributing to the observed association.

Main Methods:

  • Prospective community-based cohort study of heart failure patients (2003-2012) with vital status assessed through 2021.
  • Lipoprotein subfractions measured by nuclear magnetic resonance spectroscopy.
  • LP-IR score calculated using a composite algorithm; associations with mortality analyzed using Cox proportional hazards regression.

Main Results:

  • A one-standard deviation increase in LP-IR score was associated with a 7% reduction in mortality (HR 0.93; 95% CI, 0.97-0.99).
  • Smaller mean high-density lipoprotein (HDL) particle size was significantly associated with lower mortality (HR per 1-SD decrement = 0.83; 95% CI, 0.78-0.89).

Conclusions:

  • The LP-IR score demonstrates an inverse association with mortality in heart failure patients.
  • This protective effect may be primarily driven by smaller HDL particle size.
Abstract